Obesity trials recruiting in Florida

All Obesity trials nationally

Cities in Florida

Recruiting trials in Florida

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Clearwater, Pembroke Pines, Port Orange, St. Petersburg
• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
  NCT06143956 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Fleming Island, Miami, Miami Lakes, New Port Richey
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Plantation, Tampa
• A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
  NCT07656727 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Maitland, Miami, Port Orange
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
  NCT06672549 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Gainesville, Orlando, St. Petersburg
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
  NCT07639021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hollywood, Miramar, Ocoee
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Fleming Island, Hollywood, Saint Augustine, Winter Haven
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07481630 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hollywood, Jacksonville, Miami Lakes
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · Florida: Hollywood, Jacksonville, Weston
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Clearwater, Fleming Island, Jacksonville, Miami
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Clearwater, Coral Gables, Crystal River, Daytona Beach
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Florida: Clearwater, Fort Myers, Jacksonville, Leesburg
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Daytona Beach, Delray Beach, Fleming Island, Inverness
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Atlantis, Miami, Mt. Dora, Pembroke Pines
• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
  NCT07369011 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami, Pensacola
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Atlantis, Doral, Fleming Island, Jacksonville
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
  NCT06897475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Ocala, Oviedo
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
  NCT07215559 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Sunrise
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Boca Raton, Daytona Beach, Jacksonville, Leesburg
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
  NCT07743463 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Boca Raton, Daytona Beach, Jacksonville, Leesburg
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
  NCT07202884 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · Florida: Fort Myers, Lake Worth, Miami, Panama City
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
  NCT07575932 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hialeah, Jacksonville, Miami, Orlando
• A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
  NCT07724340 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hollywood, Tampa
• A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
  NCT07107334 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · Florida: Gainesville
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Clearwater, Jacksonville
• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
  NCT07446439 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Tampa
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
  NCT07142707 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Doral
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Kissimmee, Margate, Miami Beach, Palm Beach Gardens
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Miami, Miami Lakes, New Port Richey, Orlando
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hialeah, Hollywood, Tampa, Wellington
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Crystal River, Lecanto, Miramar, New Port Richey
• A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
  NCT07184086 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Orlando
• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
  NCT07477704 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Florida: Clearwater, Fort Myers, Sunrise, The Villages
• A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
  NCT07662122 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Florida: Miami
• A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
  NCT07441252 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Gainesville, Miami Lakes
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orlando
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
  NCT07339423 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miramar, Orlando
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Fleming Island, Jacksonville, Orlando, Oviedo
• AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571005 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami, Naples, Ocala
• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Bradenton, Naples, West Palm Beach
• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07509307 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, Naples
• Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
  NCT06602141 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · Florida: Orlando
• Association Between Body Composition and Pain in Spinal Cord Injury
  NCT05459207 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Coral Gables
• Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)
  NCT06831045 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami
• Breathing & Blood Pressure
  NCT05632406 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: All (male and female) · Florida: Tallahassee
• Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
  NCT06604650 · Phase: Not specified · Ages: 50 Years to 95 Years · Sex: All (male and female) · Florida: Miami
• Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
  NCT06595251 · Phase: Not specified · Ages: 6 Years to 14 Years · Sex: All (male and female) · Florida: Miami
• Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
  NCT06596265 · Phase: Not specified · Ages: 12 Years to 17 Years · Sex: All (male and female) · Florida: Miami
• Digitally Delivered Child Obesity Prevention for Parents in Home Visiting Programs
  NCT07230808 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 65 Years · Sex: All (male and female) · Florida: Gainesville
• Effect of Watermelon on Gut and Cardiometabolic Health
  NCT06588218 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 30 Years · Sex: All (male and female) · Florida: Tallahassee
• Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
  NCT07169136 · Phase: Not specified · Ages: 12 Years to 18 Years · Sex: Female · Florida: Jacksonville
• Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
  NCT07654361 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Florida: Clearwater, Leesburg, Miami, Ocala
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, St. Petersburg, Winter Park
• Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
  NCT07282743 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Hialeah Gardens, Lakeland, Miami, Orlando
• Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
  NCT07497880 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Jacksonville, Jupiter, Palm Springs, Pembroke Pines
• Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
  NCT07284979 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orange City
• Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
  NCT07284901 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Bradenton, Hollywood, Jupiter, Miami
• Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
  NCT07284875 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jupiter
• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
  NCT07575399 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Gainesville, Hialeah, Margate, Miami
• Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
  NCT05687188 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · Florida: Boca Raton, Edgewater, Fort Myers, Hialeah
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
  NCT07607587 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Fleming Island, Jacksonville, Pembroke Pines, Weston
• Exercise Training and Fat Metabolism in Postmenopausal Women
  NCT05351476 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: Female · Florida: Tallahassee
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
  NCT07684235 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Jacksonville, Margate, Miami, Miami Lakes
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Miami, Miami Lakes, Orlando, Weston
• FRESH-EATS Project
  NCT07053644 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
  NCT07464015 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 11 Years · Sex: All (male and female) · Florida: Orlando
• First in Human Study in Subjects With Obesity, But Otherwise Healthy
  NCT06252220 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Miami
• Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
  NCT07351110 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years and older · Sex: Female · Florida: Gainesville
• Inspiratory Muscle Strength Training in Adults With Obesity
  NCT05459636 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · Florida: Tallahassee
• Knee Injections for Obese Patients With Knee Arthritis
  NCT06782529 · Phase: Phase 4 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Florida: Jacksonville
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
  NCT07226765 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Brandon, Palmetto Bay, Pompano Beach
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
  NCT07225686 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Brandon, Palmetto Bay, Pompano Beach
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Altamonte Springs, Aventura, Boca Raton, Bradenton
• Microvascular Dysfunction in Obesity
  NCT04087655 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · Florida: Tallahassee
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Miami, Orlando, Pensacola, Sunrise
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Miami, Orlando, Pensacola, Sunrise
• Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
  NCT07446998 · Phase: Phase 2 · Ages: 65 Years to 100 Years · Sex: All (male and female) · Florida: Doral, Miami
• RESET System Pivotal Trial (Rev F)
  NCT04101669 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · Florida: Miami
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
  NCT07770841 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Delray Beach, Fort Myers, Tampa
• Respiratory Muscle Training to Improve Cerebrovascular and Immune Function
  NCT07406295 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · Florida: Tallahassee
• SMARTer Weight Loss Management
  NCT05861973 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tallahassee
• Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
  NCT07752979 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Clearwater, Lake Worth, Margate, Miramar
• Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
  NCT06585462 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Aventura, Jacksonville, Miami
• Spinal Cord Injury Model Systems (SCIMS) - Education Module
  NCT06003686 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Miami
• Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
  NCT07399678 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Miami
• Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
  NCT06562907 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Florida: Miami
• Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
  NCT07685808 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Maitland, The Villages, Winter Park
• The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
  NCT07218445 · Phase: Phase 4 · Ages: 46 Years to 60 Years · Sex: Female · Florida: Jacksonville
• Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
  NCT05561595 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gainesville
• WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)
  NCT06861790 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 75 Years · Sex: All (male and female) · Florida: Gainesville
• With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
  NCT05721976 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: Female · Florida: Miami